Efficient and Green Preparation of 9-Arylacridine-1,8-dione Derivatives 789
2×CH3), 1.09 (s, 6H, 2×CH3), 2.08–2.44 (m, 8H,
4×CH2), 5.15 (s, 1H, CH), 6.14 (s, 1H, NH), 7.50 (d,
J = 8.0 Hz, 2H, ArH), 8.06 (d, J = 8.0 Hz, 2H, ArH);
General Procedure for the Preparation of
9-Arylacridine-1,8-dione Derivatives
First, 5,5-dimethyl-1,3-cyclohexanedione (2, 0.5
mmol) and ammonium bicarbonate (3, 1.2 mmol)
13C NMR (CDCl3, 300 MHz) δ: 27.13, 29.41, 32.72,
34.40, 41.25, 50.53, 112.81, 123.37, 129.02, 145.83,
147.84, 153.68, 195.07; IR (KBr): 3444 (NH), 1643
(C O), 1604 (N C C) cm−1; MS (70 eV) m/z: 394
(M+); Anal. Calcd. for C23H26N2O4: C, 70.03; H, 6.64;
N, 7.10. Found: C, 70.20; H, 6.56; N, 7.00.
were added to
a 10-mL round bottom flask
containing 1.0 mL [bmim][BF4] and 0.05 mmol
CeCl3 · 7H2O. Then, the mixture was stirred at 55◦C
for about 3 h to complete the reaction (monitored
by TLC). Without isolating the intermediate prod-
uct, aromatic aldehyde (1, 0.5 mmol) and another
0.5 mmol of 2 were added to the reaction mixture
and let it being stirred for about another 3 h at the
temperature of 100◦C. Upon completion, the reac-
tion mixture was added with water and the solid was
collected by suction and rinsed with water and ether.
Then, the solid obtained was further purified by re-
crystallization from 95% ethanol to give the pure
products 4. All the products were fully characterized
by 1H NMR, IR, and elemental analysis. The aqueous
solution of ionic liquid together with the catalyst was
concentrated under the reduced pressure and dried
at 100◦C to recover the ionic liquid and catalyst for
the subsequent use.
3,3,6,6-Tetramethyl-9-(3-nitrophenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione (4e). 294–
1
296◦C (lit. [10a] 285–286◦C). H NMR (CDCl3, 400
MHz) δ: 0.97 (s, 6H, 2×CH3), 1.09 (s, 6H, 2×CH3),
2.13–2.43 (m, 8H, 4×CH2), 5.16 (s, 1H, CH), 6.14
(s, 1H, NH), 7.37 (t, J = 8.0 Hz, 1H, ArH), 7.86 (d,
J = 8.0 Hz, 1H, ArH), 7.94 (d, J = 8.0 Hz, 1H, ArH),
8.02 (s, 1H, ArH); IR (KBr): 3444 (NH), 1648 (C O),
1609 (N C C) cm−1.
3,3,6,6-Tetramethyl-9-(2-nitrophenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione (4f). 293–
1
295◦C. H NMR (CDCl3, 400 MHz) δ: 0.97 (s, 6H,
2×CH3), 1.07 (s, 6H, 2×CH3), 2.10–2.31 (m, 8H,
4×CH2), 5.72 (s, 1H, CH), 6.48 (s, 1H, NH), 7.19 (t,
J = 8.0 Hz, 1H, ArH), 7.41 (t, J = 8.0 Hz, 1H, ArH),
7.53 (d, J = 8.0 Hz, 1H, ArH), 7.65 (d, J = 8.0 Hz, 1H,
ArH); 13C NMR (CDCl3, 300 MHz) δ: 27.56, 28.99,
31.83, 32.51, 41.22, 50.61, 112.67, 124.16, 126.72,
131.68, 131.93, 135.32, 140.07, 148.35, 195.17; IR
(KBr): 3439 (NH), 1635 (C O), 1595 (N C C)
cm−1; MS (70 eV) m/z: 394 (M+); Anal. Calcd. for
C23H26N2O4: C, 70.03; H, 6.64; N, 7.10. Found: C,
70.18; H, 6.58; N, 7.05.
3,3,6,6-Tetramethyl-9-(4-chlorophenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione (4a). 298–
1
300◦C (lit. [10c] 296–298◦C). H NMR (CDCl3, 400
MHz) δ: 0.94 (s, 6H, 2×CH3), 1.06 (s, 6H, 2×CH3),
2.12–2.31 (m, 8H, 4×CH2), 5.05 (s, 1H, CH), 7.14 (d,
J = 8.0 Hz, 2H, ArH), 7.27 (d, J = 8.0 Hz, 2H, ArH),
7.73 (s, 1H, NH); IR (KBr): 3433 (NH), 1650 (C O),
1610 (N C C) cm−1.
3,3,6,6-Tetramethyl-9-phenyl-3,4,5,6,9,10-hexa-
hydroacridine-1,8(2H,7H)-dione (4b). 258–260◦C
3,3,6,6-Tetramethyl-9-(4-bromophenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione (4g). 312–
315◦C. 1H NMR(CDCl3, 400 MHz) δ: 0.95 (s, 6H,
2×CH3), 1.07 (s, 6H, 2×CH3), 2.12–2.35 (m, 8H,
4×CH2), 5.03 (s, 1H, CH), 6.95 (s, 1H, NH), 7.20 (d,
J = 8.0 Hz, 2H, ArH), 7.30 (d, J = 8.0 Hz, 2H, ArH);
13C NMR(CDCl3, 300 MHz) δ: 27.13, 29.49, 32.66,
33.42, 41.01, 50.70, 113.18, 119.77, 129.88, 131.00,
145.51, 148.11, 195.47; IR (KBr): 3444 (NH), 1647
(C O), 1610 (N C C) cm−1; MS (70 eV) m/z: 429
(M+ + 2), 427 (M+); Anal. Calcd. for C23H26BrNO2:
C, 64.49; H, 6.12; N, 3.27. Found: C, 64.52; H, 6.28;
N, 3.05.
1
(lit. [9] 250–252◦C). H NMR (CDCl3, 400 MHz) δ:
0.97 (s, 6H, 2×CH3), 1.08 (s, 6H, 2×CH3), 2.14–2.35
(m, 8H, 4×CH2), 5.11 (s, 1H, CH), 7.08 (t, J = 8.0
Hz, 1H, ArH), 7.20 (t, J = 8.0 Hz, 2H, ArH), 7.35 (d,
J = 8.0 Hz, 2H, ArH), 7.55 (s, 1H, NH); IR (KBr):
3439 (NH), 1640 (C O), 1606 (N C C) cm−1.
3,3,6,6-Tetramethyl-9-(4-methylphenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione (4c). 318–
320◦C (lit. [18] > 300◦C). 1H NMR (CDCl3, 400
MHz) δ: 0.94 (s, 6H, 2×CH3), 1.04 (s, 6H, 2×CH3),
2.11–2.29 (m, 11H, 4×CH2, CH3), 5.04 (s, 1H, CH),
6.97 (d, J = 8.0 Hz, 2H, ArH), 7.21 (d, J = 8.0 Hz,
2H, ArH), 7.99 (s, 1H, NH); IR (KBr): 3443 (NH),
1651 (C O), 1607 (N C C) cm−1.
3,3,6,6-Tetramethyl-9-(2-bromophenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione
(4h).
1
>300◦C(decompose). H NMR (CDCl3, 400 MHz) δ:
0.99 (s, 6H, 2×CH3), 1.07 (s, 6H, 2×CH3), 2.10–2.36
(m, 8H, 4×CH2), 5.31 (s, 1H, CH), 6.23 (s, 1H, NH),
6.92 (t, J = 8.0 Hz, 1H, ArH), 7.15 (t, J = 8.0 Hz, 1H,
3,3,6,6-Tetramethyl-9-(4-nitrophenyl)-3,4,5,6,9,
10-hexahydroacridine-1,8(2H,7H)-dione (4d). 288–
1
289◦C. H NMR (CDCl3, 400 MHz) δ: 0.95 (s, 6H,
Heteroatom Chemistry DOI 10.1002/hc